NCT00380302 - Activity of AVE1625 in Mild to Moderate Alzheimer's Patients. | Biotech Hunter

Enrollment

162

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Alzheimer Disease

Interventions

DRUG

AVE1625

Trial Locations (5)

Sanofi-Aventis Administrative Office, Bridgewater

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Milan

Sanofi-Aventis Administrative Office, Gouda

Sanofi-Aventis Administrative Office, Bromma